免费国产自久久久久三四区久久_久久99性xxx老妇胖精品_欧美女女_老司机深夜福利网站_91影视免费版在线看_91九色porny首页最多播放

position: EnglishChannel  > Global Journal Observatory> Global Journal Observatory | Serving Scientists and Scientific Development

Global Journal Observatory | Serving Scientists and Scientific Development

Source: Science and Technology Daily | 2024-12-17 15:46:54 | Author:

Founded in 1990 by the Center for Excellence in Molecular Cell Science, the Chinese Academy of Sciences and the Chinese Society for Cell Biology, Cell Research (CR) is a monthly scholarly journal that publishes peer-reviewed research articles, authoritative reviews, letters, and research highlights in the life sciences.

Over the past 34 years, CR has adhered to the ethos of "serving scientists, serving scientific development," and evolved to become the premier international journal in the field of life sciences.

Holding scientific merit as the sole metric for manuscript evaluation, CR is committed to unraveling mysteries in molecular biology, embracing breakthroughs in biotechnology, and promoting translational value from bench to bedside. The mission of CR is to disseminate the knowledge of urgent and long-standing predicaments in life sciences to drive biomedical development.

The path of scientific advancement is meandering, with numerous innovative discoveries proving unexpected, particularly when they challenge the orthodox theories. In terms of these original innovations, CR steadfastly upholds a discerning outlook and an attitude of open-mindedness and inclusivity.

For example, in 2014, Professor Yu Li from Tsinghua University discovered a new organelle called migrasome. This novel finding faced rejection from a top-tier international journal due to a reviewer's skepticism. Upon redirection to our journal, a comprehensive evaluation prompted us to acknowledge the profound significance of this discovery, leading us to solicit expert commentaries and decisively publish it expeditiously.

The publication in CR pioneered a new chapter of research and established a robust foundation for the subsequent two inclusions in Nature Cell Biology, with one featured on the cover.

In addition, CR continues to promote scientific advancement by showcasing discoveries on the formation mechanism, function, and applications of migrasomes.

This contributes to garnering attention and recognition for migrasomes globally, ultimately culminating in the triumph of Beijing Mageson Biotechnology Co., Ltd., with Yu, the founder, announcing the completion of multi-million RMB angel financing in 2023.

Aside from disseminating the transformative impact of scientific achievements and stimulating the translational values in industrial layout, CR also persists in fostering a supportive environment for scientists. The professional editorial team of CR closely engages with the frontline researchers and drives global collaboration among them.

Since 2018, CR has been dedicated to establishing the internationally renowned academic journal brand conference — Cell Research Symposia on Molecular Cell Science. This symposium aims to be at the forefront of research in molecular cell science, promote significant discoveries, facilitate exchanges and collaborations between domestic and foreign scientists, and empower China's burgeoning cohort of researchers to access the global academic arena.

Moving forward, CR will foster greater inclusiveness, transparency and innovation to illuminate the trajectory of human scientific progress in the era of big data through collaborations with other premier international journals.

Concurrently, we will endeavor to strengthen the reputation of CR as a paragon of international scholarship, thereby bolstering China's scientific and cultural prowess on the global stage.

The article is provided by the Cell Research editorial team.

Journal Review

Over the last three decades, Cell Research has advanced alongside the rapid growth of China's fundamental scientific research, particularly in life sciences. This mirrors the swift progress of the internationally renowned journal Cell, which capitalized on the wave of molecular biology at the time.

The continued investment by the state in life sciences, the return of a large number of outstanding scientists from overseas, and the unwavering support provided by organizations like the China Association for Science and Technology and the Chinese Academy of Sciences have together laid a solid foundation for the growth of Cell Research.

The accomplishments of Cell Research and other excellent journals in recent years reflect the growing maturity of China's scientific community and its increasing presence on the global stage.

Cell Research has always upheld the pursuit of excellence. Over the last 20 years, it has raised its academic standards to a level on par with renowned international journals, demonstrating resilience in its pursuit of progress. The journal is always focusing on the intrinsic originality and scholarly value of research.

I believe Cell Research will continue to contribute to creating a more balanced and fair academic publishing environment, promoting the healthy development of both scientific research and scholarly publications.

—— Pei Gang, an academician of the Chinese Academy of Sciences, and principal investigator at the Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences.

Editor:CHEN Chunyou

Top News

Jointly Protecting People's Rights in Digital Era

?Emerging technologies like AI, big data and the Internet of Things are rapidly reshaping the world in this era of digital intelligence. However, they are also bringing challenges to human rights, which makes joint efforts essential. Science and Technology Daily spoke with international experts on these issues against the backdrop of the 2025 China-Europe Seminar on Human Rights hosted by the China Society for Human Rights Studies and Cátedra China Foundation in Madrid, Spain, on June 25 on the theme "Human Rights in the Era of Digital Intelligence."

First Human Clinical Trial of Invasive BCI in China

A major breakthrough in neurotechnology has been achieved with the successful completion of China's first-in-human clinical trial of an invasive brain-computer interface (BCI) system. With that China becomes the second country in the world to reach the clinical stage in this field.

抱歉,您使用的瀏覽器版本過(guò)低或開(kāi)啟了瀏覽器兼容模式,這會(huì)影響您正常瀏覽本網(wǎng)頁(yè)

您可以進(jìn)行以下操作:

1.將瀏覽器切換回極速模式

2.點(diǎn)擊下面圖標(biāo)升級(jí)或更換您的瀏覽器

3.暫不升級(jí),繼續(xù)瀏覽

繼續(xù)瀏覽
主站蜘蛛池模板: 久久无色 | av成人亚洲 | 91一区二区| 中文成人无字幕乱码精品区 | 国产精品女人精品久久久天天 | 成人片在线免费看 | 成人免费在线网站 | 91香蕉嫩草 | 特级毛片A级毛片打开直接看 | 欧美一区二区在线视频 | 黄色一级片看看 | 日韩激情无码一级毛片 | 久久久无码精品 | av免费黄色 | 成人午夜在线免费视频 | 亚洲日本成本人观看 | 国产精品久久久久久久久久影院的 | 狠狠插久久综合网最新章节 | 国产伦精品一区二区三区视频猫咪 | 操操操日日日干干干 | 粉嫩一区二区三区 | 成人久久18免费网站麻豆 | av一级免费 | 新av在线天堂网 | 亚洲精品国产精品乱码不卞 | 国产精品久久久久免费a∨大胸 | 韩国av片免费观在线看 | 呻吟求饶的人妻中文字幕 | 亚洲精品人成 | 1区2区3区视频 | 韩国一级片免费观看 | 色久悠悠综合图区国产精品 | 久久精品久 | 少妇xxxxx性开放中出 | 国产精品无码无卡在线观看久 | 久章草在线无码视频观看 | 国产欧美综合在线观看 | 国产精品自在在线午夜蜜芽TV在线 | 久久免费看少妇高潮V片特黄 | 国产一级爱 | 国产视频精品在线 |